N/A
N=2,030
Social Media and Cancer Screening Information
Colorectal Cancer
Bottom Line
View on ClinicalTrials.gov: NCT06712901 ↗Enrolled (actual)
2,030
Serious AEs
—
Results posted
Mar 2026
Primary outcome: Primary: Intentions to Adhere to Colorectal Cancer Screening (CRCS) Recommendations — 18; 16; 21; 19 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Median Ranked Cancer Screening Messaging (Behavioral); Overall Preferred Cancer Screening Messaging (Behavioral); Black American Preferred Cancer Screening Messaging (Behavioral); White American Preferred Cancer Screening Messaging (Behavioral); Control (Behavioral)
- Age
- Adult, Older Adult · 45+ yrs
- Sex
- All
- Sponsor
- University of Utah
- Primary completion
- Jan 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Intentions to Adhere to Colorectal Cancer Screening (CRCS) Recommendations |
18; 16; 21; 19; 24; 18 | — |
| PRIMARY Intentions to Adhere Test Preference Indication |
106; 93; 118; 97; 93; 153 | — |
| SECONDARY Likelihood of Sharing Information Via Social Media |
36; 47; 47; 45; 22; 43 | — |
| SECONDARY Information Sharing Behavior |
121; 123; 127; 112; 110; 299 | — |
Summary
NORC/AmeriSpeak will recruit participants who meet the study criteria and invite them to complete a 15-minute survey. Participants will be randomly assigned to one of five conditions, with approximately 400 people in each condition, and will respond to various questions after viewing the study messaging. Once 2,000 participants complete the survey, the data will be de-identified and provided to the study team for analysis.
Eligibility Criteria
Inclusion Criteria
- Identify as white/Caucasian or Black/African American.
Exclusion Criteria
- Do not identify as white/Caucasian or Black/African American.
- Previously diagnosed with colorectal cancer
- Non-English speakers
Data sourced from ClinicalTrials.gov (NCT06712901). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.